July 23 (Reuters) - Palla Pharma Ltd PAL.AX :
* ENTERS INTO A NEW MULTI‐YEAR SUPPLY AGREEMENT WITH A EUROPEAN CUSTOMER
* 1H 2019 REVENUE IS EXPECTED TO EXCEED MAY GUIDANCE OF $24 ‐ $26 MILLION
* PAL EXPECTS TO REPORT A MODEST, MAIDEN HALF YEAR OPERATING EBITDA PROFIT
* REITERATE EXPECTATIONS OF A MODEST OPERATING EBITDA PROFIT FOR 1H 2019
* TOTAL CONTRACT REVENUE VALUE OF NOT LESS THAN US$25 MILLION
* CONFIRM ESTIMATE FOR FY 2019 REVENUE OF OVER $60 MILLION